Immunoglobulin lambda variable 1-62 (IGLV1-62)

Immunoglobulin lambda variable 1-62 (IGLV1-62) refers to a gene segment encoding a variable domain of the lambda light chain of antibodies. In the immune system, antibodies (immunoglobulins) are composed of two heavy chains and two light chains (either kappa or lambda types). Each light chain has a variable domain encoded by rearrangement of V (variable) and J (joining) gene segments. IGLV1-62 is one of several lambda variable (IGLV) gene segments that, through somatic recombination, help generate the vast diversity of antibodies needed for adaptive immunity[2]. Importantly, "IGLV1-62 (pseudogene)" is listed in some databases, indicating that this sequence may not encode a functional protein in humans and may be annotated as a pseudogene[1][4]. This gene segment is not a "target" in the conventional sense used in drug discovery (such as receptors or enzymes). There is likely a misunderstanding if this entry is being treated as a direct therapeutic target. It is a segment of the immunoglobulin gene repertoire; by itself, it does not act as a discrete, druggable entity[1][2]. IGLV1-62's biological relevance lies in its role within B-cell receptor generation, not therapeutic intervention.

Other names

IGLV1-62 (pseudogene)Immunoglobulin lambda variable region 1-62